SARAH KEECHLE: Open Payments
NPI 1215651757 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 38 payments from 13 companies in 2025. Trend: 2023 $548 · 2024 $704 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $278 |
| Axsome Therapeutics, Inc. | 3 | $94 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Almatica Pharma LLC | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, Auvelity, Jornay PM, VIVITROL, Qelbree, LOREEV XR, COBENFY, ERZOFRI EXTENDED-RELEASE.
Industry payments across OH — which companies pay providers there.
